Cargando…

Patient‐reported health outcomes in patients with non‐melanoma skin cancer and actinic keratosis: results from a large‐scale observational study analysing effects of diagnoses and disease progression

BACKGROUND: Non‐melanoma skin cancer (NMSC) and actinic keratosis (AK) are very common among fair‐skinned individuals. A disease continuum from AK to squamous cell carcinoma (SCC) has been frequently postulated. AK and NMSC may influence quality of life (QL) of patients, and it can be suspected that...

Descripción completa

Detalles Bibliográficos
Autores principales: Philipp‐Dormston, W.G., Müller, K., Novak, B., Strömer, K., Termeer, C., Hammann, U., Glutsch, J.W., Krähn‐Senftleben, G., Lübbert, H., Koller, M., Szeimies, R.M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6032898/
https://www.ncbi.nlm.nih.gov/pubmed/29150868
http://dx.doi.org/10.1111/jdv.14703
_version_ 1783337594103267328
author Philipp‐Dormston, W.G.
Müller, K.
Novak, B.
Strömer, K.
Termeer, C.
Hammann, U.
Glutsch, J.W.
Krähn‐Senftleben, G.
Lübbert, H.
Koller, M.
Szeimies, R.M.
author_facet Philipp‐Dormston, W.G.
Müller, K.
Novak, B.
Strömer, K.
Termeer, C.
Hammann, U.
Glutsch, J.W.
Krähn‐Senftleben, G.
Lübbert, H.
Koller, M.
Szeimies, R.M.
author_sort Philipp‐Dormston, W.G.
collection PubMed
description BACKGROUND: Non‐melanoma skin cancer (NMSC) and actinic keratosis (AK) are very common among fair‐skinned individuals. A disease continuum from AK to squamous cell carcinoma (SCC) has been frequently postulated. AK and NMSC may influence quality of life (QL) of patients, and it can be suspected that disease progression entails a QL reduction. The purpose of this study was to document QL in patients with NMSC and AK using the health‐outcome questionnaire EQ‐5D‐5L. METHODS: The study was designed as a non‐interventional, prospective, cross‐sectional study. Patients with AK, SCC, basal cell carcinoma (BCC) or multiple diagnoses were enrolled in this study in 29 dermatological centres across Germany. Patients were asked to complete the EQ‐5D‐5L (compromising EQ Index and EQ VAS), and the dermatologists provided diagnosis, disease history and treatment data. RESULTS: A total of 1184 patients were enrolled and diagnosed as follows: 73% AK, 49% BCC and 17% SCC. 66% had a single diagnosis, 28% two different diagnoses and 6% three different diagnoses. QL was strongly associated with patients’ diagnosis. Patients with a single AK diagnosis had significantly higher mean EQ VAS (78) than patients with BCC (74), SCC (72), and BCC plus SCC (69), P < 0.050. When the effects of disease progression were calculated, patients with AK plus SCC reported significantly less mean EQ VAS (71) than patients with a single AK diagnosis (78), P < 0.011. CONCLUSIONS: While rarely being imminently life‐threatening, NMSC and AK have an impact on QL as quantified by the EQ‐5D‐5L. This impact is associated with diagnosis (AK vs. NMSC) and clinical progression (AK vs. AK plus SCC). Both lead to a clear decline in QL. This shows that disease progression is perceived and judged as detrimental by patients and that AK and NMSC should be diligently treated to preserve and restore QL.
format Online
Article
Text
id pubmed-6032898
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-60328982018-07-12 Patient‐reported health outcomes in patients with non‐melanoma skin cancer and actinic keratosis: results from a large‐scale observational study analysing effects of diagnoses and disease progression Philipp‐Dormston, W.G. Müller, K. Novak, B. Strömer, K. Termeer, C. Hammann, U. Glutsch, J.W. Krähn‐Senftleben, G. Lübbert, H. Koller, M. Szeimies, R.M. J Eur Acad Dermatol Venereol Original Articles and Short Reports Oncology BACKGROUND: Non‐melanoma skin cancer (NMSC) and actinic keratosis (AK) are very common among fair‐skinned individuals. A disease continuum from AK to squamous cell carcinoma (SCC) has been frequently postulated. AK and NMSC may influence quality of life (QL) of patients, and it can be suspected that disease progression entails a QL reduction. The purpose of this study was to document QL in patients with NMSC and AK using the health‐outcome questionnaire EQ‐5D‐5L. METHODS: The study was designed as a non‐interventional, prospective, cross‐sectional study. Patients with AK, SCC, basal cell carcinoma (BCC) or multiple diagnoses were enrolled in this study in 29 dermatological centres across Germany. Patients were asked to complete the EQ‐5D‐5L (compromising EQ Index and EQ VAS), and the dermatologists provided diagnosis, disease history and treatment data. RESULTS: A total of 1184 patients were enrolled and diagnosed as follows: 73% AK, 49% BCC and 17% SCC. 66% had a single diagnosis, 28% two different diagnoses and 6% three different diagnoses. QL was strongly associated with patients’ diagnosis. Patients with a single AK diagnosis had significantly higher mean EQ VAS (78) than patients with BCC (74), SCC (72), and BCC plus SCC (69), P < 0.050. When the effects of disease progression were calculated, patients with AK plus SCC reported significantly less mean EQ VAS (71) than patients with a single AK diagnosis (78), P < 0.011. CONCLUSIONS: While rarely being imminently life‐threatening, NMSC and AK have an impact on QL as quantified by the EQ‐5D‐5L. This impact is associated with diagnosis (AK vs. NMSC) and clinical progression (AK vs. AK plus SCC). Both lead to a clear decline in QL. This shows that disease progression is perceived and judged as detrimental by patients and that AK and NMSC should be diligently treated to preserve and restore QL. John Wiley and Sons Inc. 2018-01-12 2018-07 /pmc/articles/PMC6032898/ /pubmed/29150868 http://dx.doi.org/10.1111/jdv.14703 Text en © 2017 The Authors. Journal of the European Academy of Dermatology and Venereology published by John Wiley & Sons Ltd on behalf of European Academy of Dermatology and Venereology. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Articles and Short Reports Oncology
Philipp‐Dormston, W.G.
Müller, K.
Novak, B.
Strömer, K.
Termeer, C.
Hammann, U.
Glutsch, J.W.
Krähn‐Senftleben, G.
Lübbert, H.
Koller, M.
Szeimies, R.M.
Patient‐reported health outcomes in patients with non‐melanoma skin cancer and actinic keratosis: results from a large‐scale observational study analysing effects of diagnoses and disease progression
title Patient‐reported health outcomes in patients with non‐melanoma skin cancer and actinic keratosis: results from a large‐scale observational study analysing effects of diagnoses and disease progression
title_full Patient‐reported health outcomes in patients with non‐melanoma skin cancer and actinic keratosis: results from a large‐scale observational study analysing effects of diagnoses and disease progression
title_fullStr Patient‐reported health outcomes in patients with non‐melanoma skin cancer and actinic keratosis: results from a large‐scale observational study analysing effects of diagnoses and disease progression
title_full_unstemmed Patient‐reported health outcomes in patients with non‐melanoma skin cancer and actinic keratosis: results from a large‐scale observational study analysing effects of diagnoses and disease progression
title_short Patient‐reported health outcomes in patients with non‐melanoma skin cancer and actinic keratosis: results from a large‐scale observational study analysing effects of diagnoses and disease progression
title_sort patient‐reported health outcomes in patients with non‐melanoma skin cancer and actinic keratosis: results from a large‐scale observational study analysing effects of diagnoses and disease progression
topic Original Articles and Short Reports Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6032898/
https://www.ncbi.nlm.nih.gov/pubmed/29150868
http://dx.doi.org/10.1111/jdv.14703
work_keys_str_mv AT philippdormstonwg patientreportedhealthoutcomesinpatientswithnonmelanomaskincancerandactinickeratosisresultsfromalargescaleobservationalstudyanalysingeffectsofdiagnosesanddiseaseprogression
AT mullerk patientreportedhealthoutcomesinpatientswithnonmelanomaskincancerandactinickeratosisresultsfromalargescaleobservationalstudyanalysingeffectsofdiagnosesanddiseaseprogression
AT novakb patientreportedhealthoutcomesinpatientswithnonmelanomaskincancerandactinickeratosisresultsfromalargescaleobservationalstudyanalysingeffectsofdiagnosesanddiseaseprogression
AT stromerk patientreportedhealthoutcomesinpatientswithnonmelanomaskincancerandactinickeratosisresultsfromalargescaleobservationalstudyanalysingeffectsofdiagnosesanddiseaseprogression
AT termeerc patientreportedhealthoutcomesinpatientswithnonmelanomaskincancerandactinickeratosisresultsfromalargescaleobservationalstudyanalysingeffectsofdiagnosesanddiseaseprogression
AT hammannu patientreportedhealthoutcomesinpatientswithnonmelanomaskincancerandactinickeratosisresultsfromalargescaleobservationalstudyanalysingeffectsofdiagnosesanddiseaseprogression
AT glutschjw patientreportedhealthoutcomesinpatientswithnonmelanomaskincancerandactinickeratosisresultsfromalargescaleobservationalstudyanalysingeffectsofdiagnosesanddiseaseprogression
AT krahnsenftlebeng patientreportedhealthoutcomesinpatientswithnonmelanomaskincancerandactinickeratosisresultsfromalargescaleobservationalstudyanalysingeffectsofdiagnosesanddiseaseprogression
AT lubberth patientreportedhealthoutcomesinpatientswithnonmelanomaskincancerandactinickeratosisresultsfromalargescaleobservationalstudyanalysingeffectsofdiagnosesanddiseaseprogression
AT kollerm patientreportedhealthoutcomesinpatientswithnonmelanomaskincancerandactinickeratosisresultsfromalargescaleobservationalstudyanalysingeffectsofdiagnosesanddiseaseprogression
AT szeimiesrm patientreportedhealthoutcomesinpatientswithnonmelanomaskincancerandactinickeratosisresultsfromalargescaleobservationalstudyanalysingeffectsofdiagnosesanddiseaseprogression
AT patientreportedhealthoutcomesinpatientswithnonmelanomaskincancerandactinickeratosisresultsfromalargescaleobservationalstudyanalysingeffectsofdiagnosesanddiseaseprogression